Skip to content

Validation of homoeopathic medicines for chronic cough

Prognostic factor assessment of homoeopathic medicines for chronic cough: Exploratory prospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/05/013973
Enrollment
5000
Registered
2018-05-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Chronic cough

Interventions

None listed

Sponsors

CCRH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Cough lasting longer than 8 weeks

Exclusion criteria

Exclusion criteria: 1.Having undergone antibiotic treatment within 7 days prior to enrolment in the study 2.Indications for referral to a specialist, like haemoptisis, or aspiration of a foreign body 3.Patients with serious hypertension • Patients on medicines with cough as adverse effects, like ACE inhibitors. • Patient who smoke. 4.Patients who abused stimulants or had an illness that make the practical participation in the trial difficult. 5.Other ongoing treatment which is likely to interfere in the course of this treatment. 6.Pregnant and lactating mothers

Design outcomes

Primary

MeasureTime frame
Prognostic relationship between diagnoses, symptoms and personal characteristics and effect of homeopathic medicines. This relationship is expressed as likelihood ratio (LR) of a diagnosis/symptom/characteristic for a specific homeopathic medicine. In total 228 diagnoses/symptoms/characteristics will be assessed.Timepoint: 6 months

Secondary

MeasureTime frame
Improvement in quality of life of patientTimepoint: 1.Quality of life (QoL): Eq-5D-5L 2.Physician rating of improvement (ORIDL) Modified Naranjoâ??s algorithm

Countries

India

Contacts

Public ContactDr Praveen Oberai

CCRH

dr.harleenkaur.ccrh@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026